Ascentage Pharma Group International
Ascentage Pharma Group International (ASPHF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ASPHF · as of Jun 8, 2026
Key Statistics
Explore Ascentage Pharma Group International Data
asphf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
asphf competitorsASPHF
AAPGV
ABCZF
ANHGY
BIESF
GALNFStock Performance
Full HistoryAbout Ascentage Pharma Group International
Ascentage Pharma Group International a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United State…
what is ascentage pharma group international · asphf stock overview · ascentage pharma group international company profile · who is ascentage pharma group international ceo · asphf OTC · ascentage pharma group international headquarters · ascentage pharma group international business segments
About Stock Overview & Key Data
Ascentage Pharma Group International (ASPHF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 21, 2021. As of the latest trading session, ASPHF stock price is $4.53, with a market capitalization of $1.7B. The stock has returned -22.16% over the past 12 months and -46.58% year-to-date.
In fiscal year 2025, Ascentage Pharma Group International reported revenue of $559.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ascentage Pharma Group International (ASPHF) stock price is $4.53. The stock is traded on OTC under the ticker symbol ASPHF. The 52-week range is $4.53 – $10.65.